Research

Psychedelic Research Recap September 2022

Over the past month, we gained some positive insights into the effectiveness ketamine in the real-world data. The official results of the first trial using LSD to treat generalized anxiety disorder were published and researchers continue to learn more about what psychedelics are doing in the brain.

Psychedelic Research Recap July & August 2022

While many of us had the chance to enjoy a vacation this summer, psychedelic researchers continued their hard work. They continued to unearth more about the therapeutic potential of these compounds. A big real-world study on at-home ketamine therapy finds promising results. At the same time, psilocybin was tested for alcoholism in a double-blind, placebo-controlled study design for the first time.

Psychedelic Research Recap June 2022

Summer is officially here and psychedelic researchers are continuing their efforts to turn these medicines into viable therapy options. Despite relatively few clinical trials being published over the month of June, we’re continuing to learn more about the effects of psychedelics through the reanalysis of existing datasets and surveys.